[Skip to Navigation]
Sign In
Research Letter
February 15, 2024

Prevalence of Immunosuppression Among US Adults

Author Affiliations
  • 1University of Washington, Seattle
JAMA. 2024;331(10):880-882. doi:10.1001/jama.2023.28019

The prevalence of immunosuppression from health conditions and medication use among US adults is often reported to be about 3%, which is based on an estimate of 2.7% from nationally representative data1 from 2013 and an estimate of 2.8% for the prevalence of immunosuppressive drug use2 among commercially insured adults younger than 65 years of age.

Add or change institution
×